Sangamo Therapeutics ran out of cash. Eli Lilly and Astellas want the science it spent decades building.

The Mission Biopharma SHAKTI scheme, launched in 2026-27, marks an important step in promoting biologics and biosimilars ...

Sangamo Therapeutics, a pioneering gene editing biotech company in the Bay Area, has filed for Chapter 11 bankruptcy protection and agreed to sell some of its programs and platforms to Eli Lilly and ...

An ethics process must not become so preoccupied with the potential harm of participation that it overlooks the certain harm ...

The era of the extract artist is over. Cannabis hit $33.8B in sales, but many operators still lack systems for scale. Here's ...

From classic family shows dating back to the '70s to modern-day sitcoms and dramedies, we've gathered the very best TV shows ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a global pharmaceutical company focused on the discovery, development and commercialization of ...

Knoa Pharma's new CEO, Michael Goettler, will lead a company that was created through Purdue Pharma's bankruptcy process.

Detailed price information for Sangamo Therapeutics Inc (SGMO) from The Globe and Mail including charting and trades.

JPMorgan initiates Wise as overweight JPMorgan said the money transfer company has plenty of upside. "We expect that Wise ...

Scientists at a NY university say they can bring back the near extinct American chestnut tree, wiped out a century ago, ...

On July 3, 2026, 50 people pledged their oath of allegiance to the United States on Fort Johnston's Garrison Lawn in Southport.